How many patents does
Regeneron Pharmaceuticals have?
patents
6,440
families
398
granted
1,192
applications
5,248
US
1,115
EP
463
JP
397
WO
396
CN
349
KR
268
RoW
3,452
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Regeneron Pharmaceuticals
Top ten assignees appearing on patents
2009 - 2018
2018
| regeneron pharmaceuticals | 988 |
| sanofi biotechnology | 51 |
| lowy, israel | 9 |
| sanofi | 2 |
| saonofi biotechnology | 1 |
| stahl, neil | 1 |
Regeneron Pharmaceuticals
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| mice expressing a light chain with human lambda variable and mouse constant regions | 169 | 2010 |
| genetically modified major histocompatibility complex mice | 90 | 2011 |
| mice that produce antigen-binding proteins with ph-dependent binding characteristics | 87 | 2012 |
| methods of treating autoimmune diseases with dll4 antagonists | 76 | 2010 |
| high affinity human antibodies to human il-4 receptor | 76 | 2006 |
| high affinity human antibodies to pcsk9 | 75 | 2008 |
| high affinity antibodies to human il-6 receptor | 74 | 2006 |
| adam6 mice | 72 | 2011 |
| common light chain mouse | 71 | 2010 |
| methods of modifying eukaryotic cells | 69 | 2000 |